Senior insider sale
TG THERAPEUTICS, INC. — senior position signals high conviction
$282.5K
17.02K shares
What this filing means
LONIAL SAGAR plans to sell 17.02K shares of TG THERAPEUTICS, INC. valued at approximately $282.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/20/2024ACC: 0001959173-24-004568
17.02K
Shares to sell
$282.5K
Approx. market value
7.43K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/18/2024
7.43KTotal acquired7.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/18/2024 | Restricted Stock Vesting Compensation | 7.43K | — |
| Total | 7.43K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.59K
Market value
$157.1K
6/17/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.43K
Market value
$125.3K
6/20/2024
Total
Units
17.02K
Value
$282.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/17/2024 | 9.59K | $157.1K | — | Completed |
| Planned — Approximate Date | ||||
6/20/2024 | 7.43K | $125.3K | NASDAQ | Planned |
| Total | 17.02K | $282.5K | ||